This inventor holds 3 USPTO granted patents. Top assignee: Alembic Pharmaceuticals Limited. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Tejas Shah: Innovator in Pharmaceutical Patents
Introduction
Tejas Shah is a prominent inventor based in Vadodara, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid-state forms of Venetoclax. With a total of 3 patents to his name, Shah is recognized for his innovative approaches to drug formulation.
Latest Patents
Shah's latest patents focus on the solid-state forms of Venetoclax and the processes for their preparation. The first patent provides novel alkali metal salt and/or DMF solvate forms of Venetoclax or its salt. This invention also outlines the process for preparing Venetoclax using the said solid-state form. The second patent reiterates similar advancements in solid-state forms of Venetoclax, emphasizing the importance of these formulations in enhancing the drug's efficacy.
Career Highlights
Tejas Shah is currently associated with Alembic Pharmaceuticals Limited, a leading pharmaceutical company. His work at Alembic has allowed him to explore innovative solutions in drug development, contributing to the company's reputation for excellence in the pharmaceutical industry.
Collaborations
Shah collaborates with talented professionals in his field, including Mahender Rao Siripragada and Chetan Patil. These collaborations enhance the research and development efforts at Alembic Pharmaceuticals, fostering an environment of innovation.
Conclusion
Tejas Shah's contributions to the pharmaceutical industry through his patents on Venetoclax solid-state forms demonstrate his commitment to advancing drug formulation technologies. His work continues to impact the field positively, showcasing the importance of innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile